Orlistat, DAG lipase-a inhibitor (TBI2448)

Description

Product Details

Formal Name: N-formyl-L-leucine (1S)-10[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester

Alternate Names: Ro18-0647; Tetrahydrolipstatin (-)

Molecular Formula: C₂₉H₅₃NO₅

Formula Weight: 495.75

CAS Number: 96829-58-2

Purity: >98%

Formulation: powder

Solubility: Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 50 mg/ml).

Storage: -20°C

Stability: ≥ 1 year.

 

Applications

DAG lipase-a inhibitor

 

Functions

A lipase inhibitor which blocks the biosynthesis of 2-AG by inhibition of DAG lipase-α.  Inhibits pancreatic lipase and other lipases but not PLA2. Inhibits fatty acid synthase and displays antitumor activity. Prevents fat absorption in the gut and is a clinically useful antiobesity agent.

 

Application Procedures

First dissolved in DMSO (up to 50 mg/ml) or in Ethanol (up to 50 mg/ml), then diluted to aqueous buffer. Solutions in DMSO or Ethanol may be stored at -20°C for up to 1 week.

Additional information

SIZE (mg)	20 MG, 100 MG

TBI2448_Orlistat